16.30 -17.00

Registration, Tea/Coffee

17.00-18.00

Sponsored Symposium
PK update in clinic: Integrase Inhibitors, Tenofovir pro-drugs and Boosters - Prof. Giovanni di Perri, University of Turin

18.00-18.40

Keynote Presentation
Challenges in Infectious Diseases - What we can Learn from IDSA - Prof. Bill Powderly, Professor of Medicine and Director of the Institute for Public Health, Washington University, St. Louis, Chief of Division of Infectious Diseases, Washington University School of Medicine.

18.40-21.00

Clinical Cases: TNFa Mutant Ninja Turtle, Even just the sound of it is something quite atrocious , A Cavitary Conundrum, Things Fall Apart

Friday, 11th May, Aula Maxima

08:00-09:00

Registration

09.00-09.05

Meeting Opening - Dr. Catherine Fleming, Galway University Hospital/NUIG, President IDSI

09.05-09.45

Keynote Presentation
Treatment of Difficult NTM Cases - Prof. Charles Daley, Professor of Medicine at National Jewish Health (NJH) and the University of Colorado Denver

09.50-10.30

Keynote Presentation
Challenges in Tuberculosis - Prof. Jon Friedland, Director of the Hammersmith Campus of Imperial College London, Head of Section, Infectious Diseases and Immunity, Honorary Consultant in Infectious Diseases, Imperial College London Healthcare NHS Trust

10.30-11.00

Coffee/Tea, Poster Viewing/Exhibition

11.00-11.30

Clinical Cases & Discussion - Prof. Charles Daley, Prof. Jon Friedland

11.30-12.30

Sponsored Symposium
Speaker: Prof Jürgen Rocktroh, Professor of Medicine and Head of the HIV Outpatient Clinic , University of Bonn

12.30-13.00

Scientific Abstracts: Oral Presentations

12.30-12.45

Assessment of the safety and immunogenicity of a heterologous prime-boost hepatitis C vaccine strategy in HIV-1 seropositive adults on antiretroviral therapy

12.45-13.00

Universal Opt-out Screening for HIV, Hepatitis B and Hepatitis C: Viability, Yield and Linkage-to-care

13.00-13.30

Lunch, Poster Viewing/Exhibition

13.30-14.30

Sponsored Symposium
HIV & Ageing: What is Normal? - Dr. Patrick Mallon, Infectious Diseases Specialist, MMUH, Associate Dean, Research & Innovation, UCD Debate: HCV treatment in the community. Can it work? Speakers: Dr. Ciaran Bannan, St. James's Hospital, Dr. Eoin Feeney, St. Vincent's University Hospital

14.30-15.15

Keynote Presentation
Diagnosis & Management of Lyme Disease - Prof. Paul Lantos, Pediatric Infectious Diseases & General Internal Medicine, Duke University School of Medicine and the Duke Global Health Institute

15.15-15.45

Scientific Abstracts: Oral Presentations

15.15-15.30

Use of Outpatient Parenteral Antimicrobial Therapy (OPAT) for Spinal Infections – an analysis of a tertiary referral centre.

15.30-15.45

Retrospective Analysis of Influenza Infected Patients 2017-2018: Lessons Learned from a Cohort Ward in a Tertiary Hospital

15.45-16.00

Tea/Coffee, Poster Viewing

16.00-17.00

Scientific Abstracts: Oral Presentations

16.00-16.15

Irish Recreational Water Consistently Contaminated with Carbapenemase-Producing Enterobacteriaceae

16.15-16.30

Hospital effluent and municipal wastewater as sources of carbapenemase-producing Enterobacteriaceae

16.30-16.45

Use of lipid lowering therapy (LLT) and achievement of recommended targets in an aging cohort of people living with HIV

16.45-17.00

Performance of Recommended Antimicrobial Investigations for Patients with Community Acquired Pneumonia admitted under a General Medical Service

17.00-17.30

Sponsored State of the Art Presentation
A clinical update on dolutegravir ▼ since IDSI 2017 - Adam Stubbs PhD

Saturday, 12th May, Aula Maxima

09.00-10.00

"Flash" Oral presentations

10.00-11.00

Sponsored Symposium
Focus on HIV Prevention - Prof. Chloe Orkin FRCP (UK), Consultant Physician, Lead for HIV and HIV/Hep C Research Ambrose King Centre, Royal London Hospital, Chair British HIV Association

11.00-11.20

Tea/Coffee, Poster Viewing

11.20-12.00

Keynote Presentation
Getting to Zero… The Dean Street Model - Dr. Emma Devitt, Consultant Physician, Chelsea & Westminster Hospital NHS Foundation Trust, London

12.00-12.45

Scientific Abstracts: Oral Presentations

12.00-12.15

Change in Soluble Glycoprotein VI (sGPVI) when Switching from ABC/3TC to TAF/FTC

12.15-12.30

Platelet Function upon Switching to TAF versus Continuing on ABC: a Randomised Sub-study

12.30-12.45

Cost minimisation analysis of a preferred ARV prescribing pathway for treatment-naïve HIV-positive patients

12:45-13:25

Keynote Presentation
The Rocky Road to HPV Prevention - Prof. Karina Butler, UCD Clinical Professor of Paediatrics, Consultant Paediatrician and Infectious Diseases Specialist, Our Lady’s Children’s Hospital and The Children’s Hospital, Temple Street

13.25-13.30

Presentation of Prizes and Close of Meeting - Dr. Helen Tuite, University Hospital Galway, Secretary IDSI 

13:30-14:00

IDSI AGM